Abgenix, Inc. (ABGX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Abgenix, Inc. (ABGX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mopgcw who wrote (297)	10/28/2003 3:27:24 AM
From: nigel bates	of 590

SLOUGH, U.K., Oct. 28, 2003 (PRIMEZONE) -- Celltech Group plc (London:CCH.L - News) (NYSE:CLL - News) today announced the achievement of a milestone in its agreement with Amgen Inc. for the research, development and global commercialisation of novel treatments for osteoporosis... ...Dr Melanie Lee, Research and Development Director for Celltech, commented: ``We are pleased that this innovative programme continues to progress well *and with the ability of our SLAM technology to generate high quality, functionally active antibodies against challenging protein targets...' Subject 33134 Exclusively licensed from ABGX by Celltech for quite a bit of cash, after ABGX acquired it in 2001*

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next